Insider Trading › RDUS › Insiders
RDUS
RDUS·Insider activity
$30.00
+0.00 (+0.00%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
RDUS
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
RDUSS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
No open-market insider purchases or sales of RDUS were filed in the last 180 days. Newest filing Nov 8, 2024 (1 year ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by RDUS insiders · Form 4 · last two years
No open-market insider buys or sells in the last two years.
On Record
$0Purchases · 180 days
$0Sales · 180 days
118Open-market transactions on record
0Insiders filing · 180 days
Purchases (code P) and sales (code S) of RDUS common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
118 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Heiskell StevenSVP & President, Recycling P&S | Sale | −9,000 | $19.52 | $176K | 121.0Kdirect | Nov 7, 2024 | Nov 8, 2024 | Form 4 ↗ |
| Vaughn James MatthewSVP, GC, CCO, Corp. Secretary | Sale | −1,379 | $16.63 | $23K | 15.0Kdirect | Nov 5, 2024 | Nov 6, 2024 | Form 4 ↗ |
| Heiskell StevenSVP & President, Recycling P&S | Sale | −17.7K | $17.08 | $302K | 133.8Kdirect | Oct 30, 2024 | Oct 31, 2024 | Form 4 ↗ |
| Gaggini Stefano R.SVP, CFO | Sale | −1,021 | $18.57 | $19K | 76.3Kdirect | May 6, 2024 | May 7, 2024 | Form 4 ↗ |
| Souza BrianSVP, Chief Ops Mgmt Officer | Sale | −4,500 | $23.49 | $106K | 18.8Kdirect | Nov 10, 2023 | Nov 14, 2023 | Form 4 ↗ |
| Heiskell StevenSVP & President, Recycling P&S | Sale | −8,000 | $24.14 | $193K | 136.4Kdirect | Nov 7, 2023 | Nov 8, 2023 | Form 4 ↗ |
| Vaughn James MatthewSVP, GC, CCO, Corp. Secretary | Sale | −571 | $24.83 | $14K | 6,608direct | Nov 6, 2023 | Nov 7, 2023 | Form 4 ↗ |
| Gaggini Stefano R.SVP, CFO | Sale | −7,269 | $24.86 | $181K | 63.3Kdirect | Nov 3, 2023 | Nov 7, 2023 | Form 4 ↗ |
| Rubric Capital Management LP10% owner | Purchase | +1.7M | $10.07 | $16.9M | 8.6Mindirect | Aug 11, 2022 | Aug 12, 2022 | Form 4 ↗ |
| Rubric Capital Management LP10% owner | Purchase | +4,012 | $10.07 | $40K | 7.0Mindirect | Aug 10, 2022 | Aug 11, 2022 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +477.8K | $5.57 | $2.7M | 8.7Mdirect | May 18, 2022 | May 20, 2022 | Form 4 ↗ |
| BIOTECH TARGET N V10% owner | Purchase | +300.0K | $6.31 | $1.9M | 8.3Mdirect | Jan 6, 2022 | Jan 7, 2022 | Form 4 ↗ |
| BIOTECH TARGET N V10% owner | Purchase | +250.0K | $6.30 | $1.6M | 8.0Mdirect | Jan 5, 2022 | Jan 7, 2022 | Form 4 ↗ |
| Rubric Capital Management LP10% owner | Purchase | +146.7K | $7.07 | $1.0M | 7.0Mindirect | Dec 16, 2021 | Dec 16, 2021 | Form 4 ↗ |
| Rosen David Efraim10% owner | Purchase | +180.7K | $6.77 | $1.2M | 6.8Mindirect | Dec 15, 2021 | Dec 15, 2021 | Form 4 ↗ |
| Rosen David Efraim10% owner | Purchase | +94.1K | $6.81 | $641K | 6.6Mindirect | Dec 14, 2021 | Dec 15, 2021 | Form 4 ↗ |
| Rosen David Efraim10% owner | Purchase | +187.4K | $7.08 | $1.3M | 6.5Mindirect | Dec 13, 2021 | Dec 15, 2021 | Form 4 ↗ |
| Rosen David Efraim10% owner | Purchase | +768.2K | $7.18 | $5.5M | 6.4Mindirect | Dec 10, 2021 | Dec 10, 2021 | Form 4 ↗ |
| Rosen David Efraim10% owner | Purchase | +264.6K | $7.58 | $2.0M | 5.6Mindirect | Dec 9, 2021 | Dec 10, 2021 | Form 4 ↗ |
| Rosen David Efraim10% owner | Purchase | +560.7K | $8.02 | $4.5M | 5.3Mindirect | Dec 8, 2021 | Dec 10, 2021 | Form 4 ↗ |
| BIOTECH TARGET N V10% owner | Purchase | +100.0K | $12.95 | $1.3M | 7.7Mdirect | Sep 29, 2021 | Oct 1, 2021 | Form 4 ↗ |
| BIOTECH TARGET N V10% owner | Purchase | +150.0K | $12.28 | $1.8M | 7.6Mdirect | Sep 22, 2021 | Sep 24, 2021 | Form 4 ↗ |
| Chopas James GeorgePrincipal Finance Accounting | Sale | −370 | $20.88 | $8K | 6,701direct | Mar 5, 2021 | Mar 9, 2021 | Form 4 ↗ |
| Grausso SalChief Commercial Officer | Sale | −1,322 | $18.93 | $25K | 11.7Kdirect | Feb 25, 2021 | Feb 26, 2021 | Form 4 ↗ |
| BIOTECH TARGET N V10% owner | Purchase | +100.0K | $14.26 | $1.4M | 7.5Mdirect | Nov 5, 2020 | Nov 9, 2020 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +200.0K | $11.69 | $2.3M | 7.4Mdirect | Sep 14, 2020 | Sep 16, 2020 | Form 4 ↗ |
| BIOTECH TARGET N V10% owner | Purchase | +199.0K | $11.33 | $2.3M | 7.2Mdirect | Sep 11, 2020 | Sep 14, 2020 | Form 4 ↗ |
| BIOTECH TARGET N V10% owner | Purchase | +25.0K | $13.21 | $330K | 7.0Mdirect | Jul 8, 2020 | Jul 9, 2020 | Form 4 ↗ |
| BIOTECH TARGET N V10% owner | Purchase | +50.0K | $15.75 | $788K | 6.9Mdirect | Apr 30, 2020 | May 4, 2020 | Form 4 ↗ |
| Hughes OwenDirector | Sale | −2,750 | $17.95 | $49K | 10.7Kdirect | Feb 26, 2020 | Feb 28, 2020 | Form 4 ↗ |
| Kelly Joseph FrancisSr. VP of Sales and Marketing | Sale | −889 | $17.93 | $16K | 24.1Kdirect | Feb 26, 2020 | Feb 28, 2020 | Form 4 ↗ |
| Morris Charles QChief Medical Officer | Sale | −1,256 | $17.93 | $23K | 33.7Kdirect | Feb 26, 2020 | Feb 28, 2020 | Form 4 ↗ |
| Rosenberg AnthonyDirector | Sale | −1,815 | $17.95 | $33K | 12.4Kdirect | Feb 26, 2020 | Feb 28, 2020 | Form 4 ↗ |
| Dere Willard HDirector | Sale | −1,925 | $17.95 | $35K | 12.2Kdirect | Feb 26, 2020 | Feb 28, 2020 | Form 4 ↗ |
| Carmona JoseChief Financial Officer | Sale | −1,292 | $17.93 | $23K | 46.7Kdirect | Feb 26, 2020 | Feb 28, 2020 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +100.0K | $23.00 | $2.3M | 6.9Mdirect | Nov 6, 2019 | Nov 8, 2019 | Form 4 ↗ |
| Rosenberg AnthonyDirector | Sale | −1,584 | $24.60 | $39K | 8,716direct | Jul 1, 2019 | Jul 3, 2019 | Form 4 ↗ |
| Kelly Joseph FrancisSr. VP of Sales and Marketing | Purchase | +2,500 | $21.81 | $55K | 7,500direct | Jun 7, 2019 | Jun 11, 2019 | Form 4 ↗ |
| Kelly Joseph FrancisSr. VP of Sales and Marketing | Purchase | +2,000 | $21.43 | $43K | 5,000direct | May 10, 2019 | May 13, 2019 | Form 4 ↗ |
| Hughes OwenDirector | Sale | −2,400 | $22.22 | $53K | 7,900direct | Apr 16, 2019 | Apr 18, 2019 | Form 4 ↗ |
| Graves KurtDirector | Sale | −4,800 | $22.32 | $107K | 5,500direct | Apr 16, 2019 | Apr 18, 2019 | Form 4 ↗ |
| Dere Willard HDirector | Sale | −1,680 | $22.22 | $37K | 8,620direct | Apr 16, 2019 | Apr 18, 2019 | Form 4 ↗ |
| Roychowdhury DebasishDirector | Sale | −4,800 | $22.15 | $106K | 5,500direct | Apr 11, 2019 | Apr 12, 2019 | Form 4 ↗ |
| Hopfield JessicaDirector | Purchase | +12.8K | $19.23 | $246K | 12.8Kdirect | Mar 5, 2019 | Mar 6, 2019 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +60.0K | $14.48 | $869K | 6.7Mdirect | Dec 20, 2018 | Dec 21, 2018 | Form 4 ↗ |
| Kelly Joseph FrancisSr. VP of Sales and Marketing | Purchase | +3,000 | $15.71 | $47K | 3,000direct | Dec 17, 2018 | Dec 18, 2018 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +60.0K | $15.64 | $938K | 6.7Mdirect | Dec 14, 2018 | Dec 17, 2018 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +60.0K | $19.65 | $1.2M | 6.6Mdirect | Aug 20, 2018 | Aug 22, 2018 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +69.4K | $20.78 | $1.4M | 6.5Mdirect | Aug 15, 2018 | Aug 16, 2018 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +100.0K | $20.87 | $2.1M | 6.5Mdirect | Aug 14, 2018 | Aug 16, 2018 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +60.0K | $22.73 | $1.4M | 6.4Mdirect | Aug 8, 2018 | Aug 10, 2018 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +50.0K | $24.81 | $1.2M | 6.3Mdirect | Jul 27, 2018 | Jul 30, 2018 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +50.0K | $27.28 | $1.4M | 6.3Mdirect | Jul 25, 2018 | Jul 26, 2018 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +50.0K | $27.36 | $1.4M | 6.2Mdirect | Jun 11, 2018 | Jun 13, 2018 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +40.0K | $28.91 | $1.2M | 6.2Mdirect | May 23, 2018 | May 24, 2018 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +60.0K | $29.27 | $1.8M | 6.1Mdirect | May 21, 2018 | May 23, 2018 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +40.0K | $33.80 | $1.4M | 6.1Mdirect | Apr 19, 2018 | Apr 23, 2018 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +50.0K | $36.58 | $1.8M | 5.9Mdirect | Apr 5, 2018 | Apr 9, 2018 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +80.0K | $32.52 | $2.6M | 5.9Mdirect | Mar 2, 2018 | Mar 6, 2018 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +75.0K | $34.38 | $2.6M | 5.8Mdirect | Feb 9, 2018 | Feb 12, 2018 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +50.0K | $26.25 | $1.3M | 5.7Mdirect | Nov 14, 2017 | Nov 16, 2017 | Form 4 ↗ |
| Hatzis-Schoch BrentSr. VP, General Counsel | Purchase | +1,778 | $28.09 | $50K | 2,278direct | Nov 10, 2017 | Nov 13, 2017 | Form 4 ↗ |
| Hoiland JesperPresident and CEO · Director | Purchase | +6,800 | $29.04 | $197K | 12.9Kdirect | Nov 7, 2017 | Nov 7, 2017 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +50.0K | $29.15 | $1.5M | 5.6Mdirect | Nov 3, 2017 | Nov 7, 2017 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +50.0K | $30.95 | $1.5M | 5.6Mdirect | Oct 26, 2017 | Oct 27, 2017 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +50.0K | $32.85 | $1.6M | 5.5Mdirect | Oct 25, 2017 | Oct 26, 2017 | Form 4 ↗ |
| Hoiland JesperPresident and CEO · Director | Purchase | +6,100 | $32.72 | $200K | 6,100direct | Sep 15, 2017 | Sep 15, 2017 | Form 4 ↗ |
| Carmona JoseChief Financial Officer | Purchase | +3,000 | $32.83 | $98K | 3,000direct | Sep 14, 2017 | Sep 15, 2017 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +50.0K | $32.94 | $1.6M | 5.5Mdirect | Sep 14, 2017 | Sep 15, 2017 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +100.0K | $33.71 | $3.4M | 5.4Mdirect | Sep 13, 2017 | Sep 15, 2017 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +50.0K | $35.42 | $1.8M | 5.3Mdirect | Sep 12, 2017 | Sep 13, 2017 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +50.0K | $36.75 | $1.8M | 5.3Mdirect | Sep 5, 2017 | Sep 7, 2017 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +60.0K | $35.98 | $2.2M | 5.2Mdirect | Aug 16, 2017 | Aug 18, 2017 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +75.0K | $34.26 | $2.6M | 5.2Mdirect | Aug 10, 2017 | Aug 11, 2017 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +75.0K | $35.67 | $2.7M | 5.1Mdirect | Aug 9, 2017 | Aug 11, 2017 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +40.0K | $34.21 | $1.4M | 5.0Mdirect | May 30, 2017 | May 31, 2017 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +40.0K | $36.25 | $1.4M | 5.0Mdirect | May 25, 2017 | May 30, 2017 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +50.0K | $34.41 | $1.7M | 5.0Mdirect | May 18, 2017 | May 22, 2017 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +18.0K | $32.98 | $594K | 4.9Mdirect | May 17, 2017 | May 18, 2017 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +17.0K | $33.93 | $577K | 4.9Mdirect | May 16, 2017 | May 18, 2017 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +15.0K | $34.00 | $510K | 4.9Mdirect | May 12, 2017 | May 16, 2017 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +50.0K | $35.93 | $1.8M | 4.9Mdirect | May 9, 2017 | May 11, 2017 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +22.8K | $35.60 | $812K | 4.8Mdirect | May 8, 2017 | May 9, 2017 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +20.6K | $35.55 | $732K | 4.8Mdirect | May 5, 2017 | May 9, 2017 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +75.0K | $33.91 | $2.5M | 4.8Mdirect | May 2, 2017 | May 3, 2017 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +150.0K | $35.39 | $5.3M | 4.7Mdirect | May 1, 2017 | May 2, 2017 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +50.0K | $35.83 | $1.8M | 4.5Mdirect | Mar 21, 2017 | Mar 22, 2017 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +30.0K | $38.41 | $1.2M | 4.5Mdirect | Mar 17, 2017 | Mar 21, 2017 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +44.5K | $39.96 | $1.8M | 4.5Mdirect | Mar 15, 2017 | Mar 16, 2017 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +17.3K | $40.00 | $690K | 4.4Mdirect | Mar 14, 2017 | Mar 16, 2017 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +38.3K | $39.17 | $1.5M | 4.4Mdirect | Mar 10, 2017 | Mar 14, 2017 | Form 4 ↗ |
| Fitzpatrick Lorraine A.Chief Medical Officer | Purchase | +100 | n/c | — | 200direct | Jan 25, 2016 | Jan 26, 2016 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +38.3K | $31.67 | $1.2M | 4.4Mdirect | Jan 22, 2016 | Jan 25, 2016 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +50.0K | $39.90 | $2.0M | 4.3Mdirect | Jan 13, 2016 | Jan 14, 2016 | Form 4 ↗ |
| Fitzpatrick Lorraine A.Chief Medical Officer | Purchase | +100 | $60.60 | $6K | 100direct | Nov 25, 2015 | Jan 26, 2016 | Form 4 ↗ |
| Ward RobertPresident & CEO · Director | Sale | −25.0K | $62.77 | $1.6M | 0direct | Nov 23, 2015 | Nov 25, 2015 | Form 4 ↗ |
| Hattersley GaryChief Scientific Officer | Sale | −5,683 | $75.00 | $426K | 0direct | Nov 12, 2015 | Nov 13, 2015 | Form 4 ↗ |
| Hattersley GaryChief Scientific Officer | Sale | −13.3K | $70.00 | $933K | 0direct | Nov 3, 2015 | Nov 5, 2015 | Form 4 ↗ |
| Hattersley GaryChief Scientific Officer | Sale | −11.3K | $65.00 | $735K | 0direct | Oct 23, 2015 | Oct 27, 2015 | Form 4 ↗ |
| Hattersley GaryChief Scientific Officer | Sale | −1,501 | $65.36 | $98K | 0direct | Oct 21, 2015 | Oct 23, 2015 | Form 4 ↗ |
| Snow David P.Chief Commercial Officer | Purchase | +6,000 | $69.79 | $419K | 6,000direct | Sep 14, 2015 | Sep 28, 2015 | Form 4 ↗ |
| Purandare DineshSVP Global Oncology/Commercial | Purchase | +200 | $62.20 | $12K | 200direct | Aug 31, 2015 | Sep 8, 2015 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +50.0K | $63.45 | $3.2M | 4.3Mdirect | Aug 21, 2015 | Aug 24, 2015 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +50.0K | $64.56 | $3.2M | 4.2Mdirect | Aug 20, 2015 | Aug 24, 2015 | Form 4 ↗ |
| Graves KurtDirector | Sale | −22.7K | $70.00 | $1.6M | 0direct | Aug 17, 2015 | Aug 19, 2015 | Form 4 ↗ |
| Graves KurtDirector | Sale | −2,306 | $70.00 | $161K | 0direct | Aug 10, 2015 | Aug 12, 2015 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +250.0K | $74.00 | $18.5M | 4.2Mdirect | Jul 23, 2015 | Jul 27, 2015 | Form 4 ↗ |
| Graves KurtDirector | Sale | −25.0K | $69.48 | $1.7M | 0direct | Jul 6, 2015 | Jul 8, 2015 | Form 4 ↗ |
| Graves KurtDirector | Sale | −25.0K | $55.05 | $1.4M | 0direct | Jun 18, 2015 | Jun 22, 2015 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +50.0K | $36.46 | $1.8M | 3.9Mdirect | May 1, 2015 | May 4, 2015 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +50.0K | $36.23 | $1.8M | 3.9Mdirect | Apr 29, 2015 | Apr 30, 2015 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +50.0K | $36.59 | $1.8M | 3.8Mdirect | Apr 28, 2015 | Apr 29, 2015 | Form 4 ↗ |
| BB BIOTECH AG10% owner | Purchase | +50.0K | $38.38 | $1.9M | 3.8Mdirect | Apr 27, 2015 | Apr 29, 2015 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +75.0K | $47.08 | $3.5M | 3.7Mdirect | Mar 6, 2015 | Mar 9, 2015 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +35.0K | $45.74 | $1.6M | 3.6Mdirect | Feb 25, 2015 | Feb 27, 2015 | Form 4 ↗ |
| F2 Bioscience IV GP Ltd.10% owner | Purchase | +587.5K | $8.00 | $4.7M | 587.5Kindirect | Jun 11, 2014 | Jun 13, 2014 | Form 4 ↗ |
| Jovan-Embiricos MoranaDirector · 10% owner | Purchase | +587.5K | $8.00 | $4.7M | 587.5Kindirect | Jun 11, 2014 | Jun 13, 2014 | Form 4 ↗ |
| BIOTECH GROWTH N V10% owner | Purchase | +1.0M | $8.00 | $8.0M | 2.7Mdirect | Jun 6, 2014 | Jun 12, 2014 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →